Development of α-tocopherol acetate nanoparticles: Influence of preparative processes

Drug Development and Industrial Pharmacy

Volumn 35, Issue 2, 2009, Pages 216-223

  Anais, J P ^a   Razzouq, N ^a   Carvalho, M ^a   Fernandez, C ^a   Astier, A ^a,b   Paul, M ^a   Fessi, H ^c   Lorino, A M ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

tocopherol acetate; Cigarette smoke toxicity; Emulsification diffusion; Nanoparticles; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CIGARETTE SMOKE; NANOCAPSULE; NANOSPHERE; POLYLACTIDE; POLYMER; SOLVENT;

ADSORPTION; AEROSOL; ARTICLE; DIFFUSION; DRUG ADSORPTION; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TARGETING; EMULSION; EVAPORATION; FREEZE DRYING; INTERMETHOD COMPARISON; LUNG TOXICITY; MOLECULAR PHYSICS; MOLECULAR SIZE; MOLECULAR STABILITY; NANOENCAPSULATION; PHYSICAL CHEMISTRY; PRECIPITATION; ZETA POTENTIAL;

AEROSOLS; ALPHA-TOCOPHEROL; ANTIOXIDANTS; DIFFUSION; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; LUNG; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; TOBACCO; TOBACCO SMOKE POLLUTION;

EID: 60749137135     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802248798     Document Type: Article

References (36)

1. Ammoury, N. (1990). Etude physicochimique et biologique de vecteurs colloidaux vésiculaires d'indométacine - acide polylactique. Ph.D., Thesis, University Paris XI.
2. Ammoury, N., Fessi, H., Devissaguet, J. P., Puisieux, F., & Benita, S. (1989). Physicochemical characterization of polymeric nanocapsules and in vitro release evaluation of indomethacin as a drug model. STP. Pharma., 5, 647-651.
3. Auvillain, M., Cavé, G., Fessi, H., & Devissaguet, J. P. (1989). Lyophilisation de vecteurs colloidaux submicroniques. STP Pharma., 5, 738-744.
4. Bosquillon, C., Rouxhet, P. G., Ahimou, F., Simon, D., Culot, C., Préat, V., & Vanbever, R. (2004). Aerosolization properties, surface composition and physical state of spray-dried protein powders. J. Control. Release, 99, 357-367.
5. Bouchemal, K., Briançon, S., Perrier, E., Fessi, H., Bonnet, I., & Zydowicz, N. (2004). Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. Int. J. Pharm., 269, 89-100.
6. Chow, C. K., Chen, L. H., Thacker, R. R., & Griffith, R. B. (1984). Dietary vitamin E and pulmonary biochemical responses of rats to cigarette smoking. Environ. Res., 34, 8-17.
7. Dailey, L. A., Schmehl, T., Gessler, T., Wittmar, M., Grimminger, F., Seeger, W., & Kissel, T. (2003). Nebulization of biodegradable nanoparticles: Impact of nebulizer technology and nanoparticle characteristics on aerosol features. J. Control. Release, 86, 131-144.
8. Duclairoir, C., Orecchioni, A. M., Depraetere, P., & Nakache, E. (2002). Alpha-tocopherol encapsulation and in vitro release form wheat gliadin nanoparticles. J. Microencapsul., 19, 53-60.
9. Fessi, H., Devissaguet, J. P., & Puisieux, F. (1988). Procédé de préparation de systèmes colloidaux dispersibles d'une substance sous forme de nanoparticules. French Patent. No. 2-608-988.
10. Fiegel, J., Fu, J., & Hanes, J. (2004). Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. J. Control. Release, 96, 411-423.
11. Food and Drug Administration HHS. (1997). International conference on harmonization: Guidance on impurities: residual solvents. Fed. Regist., 62, 67377-67388.
12. Fu, J., Fiegel, J., Krauland, E., & Hanes, J. (2002). New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials, 23, 4425-4433.
13. Fukuzawa, K., Ikebata, W., & Sohmi, K. (1993). Location, antioxidant and recycling dynamics of (-tocopherol in liposome membranes. J. Nutr. Sci. Vitaminol., 39, S9-S22.
14. Hautamaki, R. D., Kobayashi, D. K., Senior, R. M., & Shapiro, S. D. (1997). Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science, 277, 2002-2004.
15. Jalil, R., & Nixon, J. R. (1990). Microencapsulation using poly (l- lactic acid) II: Preparative variables affecting microcapsules properties. J. Microencapsul., 7, 25-39.
16. Johnson, C. E. (1989). Principles of nebulizer-delivered drug therapy for asthma. Am. J. Hosp. Pharm., 46, 1845-1855.
17. Kato, Y., Watanabe, K., Nakakura, M., Hosokawa, T., Hayakawa, E., & Ito, K. (1993). Blood clearance and tissue distribution of various formulations of ?-tocopherol injection after intravenous administration. Chem. Pharm. Bull., 41, 599-604.
18. Losowsky, M. S., Kelleher, J., & Walker, B. E. (1972). Intake and absorption of α-tocopherol. Ann. NY Acad. Sci., 203, 212-222.
19. McCallion, O. N. M., Taylor, K. M. G., Thomas, M., & Taylor, A. J. (1996). Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers. Int. J. Pharm., 133, 203-214.
20. Newhouse, M. C. (1982). Principles of aerosolization therapy. Chest, 82S, 395-445.
21. Pacht, E. R., Kaseki, H., Mohammed, J. R., Cornwell, D. G., & Davis, W. B. (1986). Deficiency of vitamin E in the alveolar fluid of cigarette smokers. J. Clin. Invest., 77, 789-796.
22. Panda, K., Chattopadhyay, R., Ghosh, M. K., Chattopadhyay, D. J., & Chatterjee, I. B. (1999). Vitamin C prevents cigarette smoke induced oxidative damage of proteins and increased proteolysis. Free. Radic. Biol. Med., 27, 1064-1079.
23. Quintanar-Guerrero, D., Fessi, H., Alléman, E., & Doelker, E. (1996). Influence of stabilizing agents and preparative variables on the formation of poly (D, L-lactic acid) nanoparticles by an emulsification- diffusion technique. Int. J. Pharm., 143, 133-141.
24. Roy, D., Guillon, X., Lescure, F., Couvreur, P., Bru, N., & Breton, P. (1997). On shelf stability of freeze-dried poly (methylidene malonate 2.1.2) nanoparticles. Int. J. Pharm., 148, 165-175.
25. Scherrer-Crosbie, M., Paul, M., Meignan, M., Dahan, E., Lagrue, G., Atlan, G., & Lorino, A. M. (1996). Pulmonary clearance and lung function: Influence of acute tobacco intoxication and of vitamin E. J. Appl. Physiol., 81, 1071-1077.
26. Schmekel, B., Bos, J. A. H., Khan, A. R., Wohlfart, B., Lachmann, B., & Wollmer, P. (1992). Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. Thorax, 47, 603-608.
27. Schreier, H., Gonzalez-Rothi, R. J., & Stecenko, A. A. (1993). Pulmonary delivery of liposome. J. Control. Release, 24, 209-223.
28. Shek, P. N., Suntres, Z. E., & Brooks, J. I. (1994). Liposomes in pulmonary applications: Physicochemical considerations, pulmonary distribution and antioxidant delivery. J. Drug. Target., 2, 431-442.
29. Shvedova, A. A., Kisin, E. R., Murray, A. R., Gorelik, O., Arepalli, S., Castranova, V., Young, S. H., Gao, F., Tyurina, Y. Y., Oury, T. D., & Kagan, V. E. (2007). Vitamin e deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol. Appl. Pharmacol., 221, 339-348.
30. Stolnik, S., Davies, M. C., Illum, L., Davis, S. S., Boustta, M., & Vert, M. (1994). The preparation of sub -200 nm biodegradable colloidal particles from poly (malic acid-co-benzyl-malate) copolymers and their surface modification with poloxamer and poloxamine surfactants. J. Control. Release, 30, 57-67.
31. Suntres, Z. E., Hepworth, S. R., & Shek, P. N. (1992). Protective effect of liposome associated α-tocopherol against paraquat- induced acute lung toxicity. Biochem. Pharmacol., 44, 1811-1818.
32. Suntres, Z. E., & Shek, P. N. (1995a). Intratracheally administered liposomal alpha-tocopherol protects the lung against long-term toxic effects of paraquat. Biomed. Environ. Sci., 8, 289-300.
33. Suntres, Z. E., & Shek, P. N. (1995b). Prevention of phorbol-myristate acetate-induced acute lung injury by α-tocopherol liposomes. J. Drug. Target., 3, 201-208.
34. Taburet, A. M., & Schmit, B. (1994). Pharmacokinetic optimization of asthma treatment. Clin. Pharmacokinet., 26, 396-418.
35. Venier-Julienne, M. C., Vouldoukis, I., Monjour, L., & Benoit, J. P. (1995). In vitro study of the antileishmanial activity of biodegradable nanoparticles. J. Drug. Target., 3, 23-29.
36. Zaru, M., Mourtas, S., Klepetsanis, P., Fadda, A. M., & Antimisiaris, S. G. (2007). Liposomes for drug delivery to the lungs by nebulization. Eur. J. Pharm. Biopharm., 67, 655-66.